Valuation: Evotec SE

Market Cap 667M 763M 616M 569M 1.07B 73.26B 1.09B 7.35B 2.88B 35.88B 2.87B 2.8B 124B P/E 2026 *
-5.23x
P/E 2027 * -14.9x
Enterprise Value 668M 764M 618M 571M 1.07B 73.43B 1.09B 7.37B 2.89B 35.96B 2.87B 2.81B 124B EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.91x
Free-Float
89.91%
Yield 2026 *
-
Yield 2027 * -
1 day-4.85%
1 week-25.60%
Current month-24.97%
1 month-21.35%
3 months-30.43%
6 months-41.46%
Current year-31.19%
1 week 3.18
Extreme 3.176
5.1
1 month 3.18
Extreme 3.176
5.23
Current year 3.18
Extreme 3.176
6.73
1 year 3.18
Extreme 3.176
7.84
3 years 3.18
Extreme 3.176
24.44
5 years 3.18
Extreme 3.176
45.83
10 years 3.18
Extreme 3.176
45.83
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO - 2026-04-30
Chief Operating Officer - 2026-04-30
Director TitleAgeSince
Director/Board Member 58 2019-06-18
Director/Board Member 64 2021-05-31
Director/Board Member 43 2022-06-21
Date Insider Type Main position Quantity % Market Cap.
Jun. 14Sell

Chief Technology Officer

-119,900 0.0674%
May. 19Fiscal year

Chief Technology Officer

12,462 0.0070%
May. 03Buy 15,510 0.0087%
Change 5-day change 1-year change 3-year change Capi.($)
-6.05%-25.60%-47.21%-82.88% 763M
-0.24%+1.39%+3.15%+6.98% 50.35B
+0.55%-2.88%+382.07%+593.81% 39.32B
+0.13%-0.19%+29.79%-6.00% 34.69B
+0.86%-0.78%+21.58%+56.15% 34.08B
-1.31%-3.03%+2.51%+25.24% 26.63B
+0.13%-0.52% - - 16.49B
+1.13%-1.85%+67.36%+120.46% 15.31B
+0.09%+2.74%+14.30%+17.30% 13.8B
+1.13%-0.44%+12.34%-31.79% 12.87B
Average -0.26%-3.43%+53.99%+77.70% 24.43B
Weighted average by Cap. +0.16%-0.99%+80.64%+121.55%

Financials

2026 *2027 *
Net sales 719M 822M 664M 614M 1.16B 79B 1.18B 7.92B 3.11B 38.68B 3.09B 3.02B 133B 810M 927M 749M 692M 1.3B 89.06B 1.33B 8.93B 3.5B 43.61B 3.48B 3.41B 150B
Net income -113M -130M -105M -96.71M -182M -12.45B -185M -1.25B -490M -6.09B -487M -476M -20.98B -30.42M -34.81M -28.12M -25.98M -48.93M -3.34B -49.81M -335M -132M -1.64B -131M -128M -5.64B
Net Debt 1.53M 1.75M 1.42M 1.31M 2.47M 169M 2.51M 16.9M 6.63M 82.53M 6.59M 6.44M 284M 69.32M 79.33M 64.09M 59.21M 111M 7.62B 114M 764M 300M 3.73B 298M 291M 12.85B
Logo Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Employees
4,526
Date Price Change Volume
26-07-14 3.750 -24.12% 6,997,362
26-07-13 €4.942 -0.08% 371,645
26-07-10 €4.946 -0.88% 342,438
26-07-09 €4.990 +2.00% 289,624
26-07-08 €4.892 -2.94% 420,508
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
3.750EUR
Average target price
6.443EUR
Spread / Average Target
+71.81%

Quarterly revenue - Rate of surprise